GlassScriptPhysician profile
Ismael Lopez
NPI 1235110495
$50,473.18
in general payments reported to CMS, 2019-2025
33 companies · $4,582 in 2025
The $4,582 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,994 · 2022: $7,204 · 2023: $22K · 2024: $14K · 2025: $4,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Consulting Fee: $11K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,063 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,166.72 |
| Consulting Fee | $11,178.10 |
| Food and Beverage | $10,847.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,062.50 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $22,290.22 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Heartflow, INC. | $9,636.71 | 2021-2025 | Ffrct |
| Biotronik INC. | $6,150.59 | 2021-2025 | Biomonitor, Acticor 7 Vr-T Dx, Rivacor 7 Dr-T |
| Medtronic, INC. | $3,337.78 | 2021-2025 | Micra, Endurant Iis, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $1,806.85 | 2021-2025 | Cardiomems, Jot Dx, Diamondback Coronary |
| Cvrx, INC. | $1,702.46 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $1,292.81 | 2021-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $625.54 | 2021-2025 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Ams 700 |
| Edwards Lifesciences Corporation | $432.48 | 2022-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $327.44 | 2021-2025 | Jardiance |
| Abiomed | $293.93 | 2023-2025 | Impella |
| Chiesi USA, INC. | $285.38 | 2021-2024 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $247.14 | 2021-2024 | Xarelto |
| Amgen INC. | $225.83 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $219.88 | 2021-2025 | Lifevest |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $200.41 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $185.92 | 2021-2022 | |
| Cardiovascular Systems INC. | $159.66 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $146.22 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Organogenesis INC. | $125.74 | 2021-2022 | |
| Shockwave Medical, INC | $123.66 | 2025 | |
| Inspiremd LTD | $112.16 | 2025 | Cguard Prime Carotid Stent System |
| Actelion Pharmaceuticals US, INC. | $98.29 | 2023 | Opsumit, Uptravi |
| Pfizer INC. | $91.10 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $71.71 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $61.44 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $58.44 | 2024-2025 | Ozempic, Rybelsus |
| Cleerly, INC. | $47.39 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Atricure, INC. | $29.42 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Novartis Pharmaceuticals Corporation | $24.75 | 2025 | |
| Tactile Systems Technology INC | $22.74 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $21.48 | 2023 | Inpefa |
| Esperion Therapeutics, INC. | $17.61 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ismael Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.